Rituximab in ANCA-Associated Vasculitis: Fad or Fact?

被引：9

作者：

Fervenza, Fernando C. ^{[1
]}

机构：

[1] Mayo Clin, Coll Med, Div Nephrol & Hypertens, Rochester, MN 55901 USA

来源：

NEPHRON CLINICAL PRACTICE | 2011年 / 118卷 / 02期

关键词：

Rituximab; High-dose glucocorticosteroids; Cyclophosphamide; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CHURG-STRAUSS-SYNDROME; REFRACTORY WEGENERS-GRANULOMATOSIS; B-LYMPHOCYTE DEPLETION; MICROSCOPIC POLYANGIITIS; MAINTENANCE THERAPY; CYCLOPHOSPHAMIDE; RELAPSE; CELLS;

D O I：

10.1159/000321437

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

A number of case reports and case series of patients with Wegener's granulomatosis, microscopic polyangiitis and Churg-Strauss syndrome have supported the use of rituximab (RTX) for the treatment of refractory ANCA-associated vasculitis (AAV). Whether B cell depletion with RTX could replace cyclophosphamide as a first-line therapy for patients with severe AAV remains to be proven. Two studies, recently published in the New England Journal of Medicine, have examined the efficacy of RTX in inducing remission in patients with severe AAV. Copyright (C) 2010 S. Karger AG, Basel

引用

页码：C182 / C188

页数：7

共 50 条

[41] Vasculitis for the internist: focus on ANCA-associated vasculitis [J].

Chaigne, Benjamin ;

Guillevin, Loic .

INTERNAL AND EMERGENCY MEDICINE, 2017, 12 (05) :577-585

[42] ANCA-associated vasculitis [J].

Holle, J. U. .

ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 (05) :445-456

[43] ANCA-associated vasculitis [J].

Holle, J. U. .

INTERNIST, 2015, 56 (01) :41-52

[44] ANCA-associated vasculitis [J].

Kitching, A. Richard ;

Anders, Hans-Joachim ;

Basu, Neil ;

Brouwer, Elisabeth ;

Gordon, Jennifer ;

Jayne, David R. ;

Kullman, Joyce ;

Lyons, Paul A. ;

Merkel, Peter A. ;

Savage, Caroline O. S. ;

Specks, Ulrich ;

Kain, Renate .

NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01)

[45] Modern therapeutic approach to ANCA-associated vasculitis [J].

Coaccioli, S. ;

Candelori, A. ;

Puxeddu, A. .

CLINICA TERAPEUTICA, 2009, 160 (01) :69-82

[46] Development of morbidity and mortality in ANCA-associated vasculitis [J].

Reinhold-Keller, E. ;

Moosig, F. .

ZEITSCHRIFT FUR RHEUMATOLOGIE, 2011, 70 (06) :486-+

[47] Avacopan for the treatment of ANCA-associated vasculitis [J].

Osman, Mohammed ;

Cohen Tervaert, Jan Willem ;

Pagnoux, Christian .

EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (07) :717-726

[48] Remission induction in ANCA-associated vasculitis [J].

Hellmich, B. .

ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (02) :194-195

[49] Treatment of Relapses in ANCA-Associated Vasculitis [J].

McClure, Mark ;

Jones, Rachel B. .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (07) :967-969

[50] Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis [J].

McClure, Mark E. ;

Wason, James ;

Gopaluni, Seerapani ;

Tieu, Joanna ;

Smith, Rona M. ;

Jayne, David R. ;

Jones, Rachel B. .

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 (05) :217-223

← 1 2 3 4 5 →